Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Long-Term Deferred Tax (2016)

Historic Long-Term Deferred Tax for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Q4 2016 value amounting to $10.3 million.

  • Avadel Pharmaceuticals' Long-Term Deferred Tax fell 1069.86% to $10.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $10.3 million, marking a year-over-year decrease of 1069.86%. This contributed to the annual value of $10.3 million for FY2016, which is 1069.86% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Long-Term Deferred Tax stood at $10.3 million for Q4 2016, which was down 1069.86% from $11.2 million recorded in Q3 2016.
  • Over the past 5 years, Avadel Pharmaceuticals' Long-Term Deferred Tax peaked at $13.1 million during Q4 2014, and registered a low of -$14.1 million during Q4 2012.
  • Over the past 5 years, Avadel Pharmaceuticals' median Long-Term Deferred Tax value was $11.4 million (recorded in 2015), while the average stood at $7.6 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Long-Term Deferred Tax soared by 56692.8% in 2014, and later crashed by 1160.89% in 2015.
  • Avadel Pharmaceuticals' Long-Term Deferred Tax (Quarter) stood at -$14.1 million in 2012, then soared by 80.14% to -$2.8 million in 2013, then skyrocketed by 566.93% to $13.1 million in 2014, then decreased by 11.61% to $11.6 million in 2015, then fell by 10.7% to $10.3 million in 2016.
  • Its last three reported values are $10.3 million in Q4 2016, $11.2 million for Q3 2016, and $11.4 million during Q2 2016.